Coronacept - a potent immunoadhesin against SARS-CoV-2
H. Cohen-Dvashi, J. Weinstein, M. Katz, M. Eilon, Y. Mor, A. Shimon, R. Strobelt, M. Shemesh, S. J. Fleishman, R. Diskin
The paper describes the design of a modified human ACE2 immunoadhesin with enhanced affinity for SARS-CoV-2 spike protein, showing its potential as an antiviral agent.
bioRxiv · Aug 12, 2020 · PreprintBioengineering